본문 바로가기
KERD
논문KCI 등재

The protective effects of Aster yomena (Kitam.) Honda on high-fat diet-induced obese C57BL/6J mice

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

BACKGROUND/OBJECTIVES: Aster yomena (Kitam.) Honda (AY) has remarkable bioactivities, such as antioxidant, anti-inflammation, and anti-cancer activities. On the other hand, the effects of AY against obesity-induced insulin resistance have not been reported. Therefore, this study examined the potential of AY against obesity-associated insulin resistance in high-fat diet (HFD)-fed mice. MATERIALS/METHODS: An obesity model was established by feeding C57BL/6J mice a 60% HFD for 16 weeks. The C57BL6/When ethyl acetate fraction from AY (EFAY) at doses of 100 and 200 mg/kg/day was administered orally to mice fed a HFD for the last 4 weeks. Normal and control groups were administered water orally. The body weight and fasting blood glucose were measured every week. Dietary intake was measured every other day. After dissection, blood and tissues were collected from the mice. RESULTS: The administration of EFAY reduced body and organ weights significantly compared to HFD-fed control mice. The EFAY-administered groups also improved the serum lipid profile by decreasing the triglyceride, total cholesterol, and low-density lipoprotein compared to the control group. In addition, EFAY ameliorated the insulin resistance-related metabolic dysfunctions, including the fasting blood glucose and serum insulin level, compared to the HFD-fed control mice. The EFAY inhibited lipid synthesis and insulin resistance by down-regulation of hepatic fatty acid synthase and up-regulation of the AMP-activated protein kinase pathway. EFAY also reduced lipid peroxidation in the liver, indicating that EFAY protected hepatic injury induced by obesity. CONCLUSIONS: These results suggest that EFAY improved obesity-associated insulin resistance by regulating the lipid and glucose metabolism, suggesting that AY could be used as a functional food to prevent obesity and insulin resistance.

Abstract

BACKGROUND/OBJECTIVES: Aster yomena (Kitam.) Honda (AY) has remarkable bioactivities, such as antioxidant, anti-inflammation, and anti-cancer activities. On the other hand, the effects of AY against obesity-induced insulin resistance have not been reported. Therefore, this study examined the potential of AY against obesity-associated insulin resistance in high-fat diet (HFD)-fed mice. MATERIALS/METHODS: An obesity model was established by feeding C57BL/6J mice a 60% HFD for 16 weeks. The C57BL6/When ethyl acetate fraction from AY (EFAY) at doses of 100 and 200 mg/kg/day was administered orally to mice fed a HFD for the last 4 weeks. Normal and control groups were administered water orally. The body weight and fasting blood glucose were measured every week. Dietary intake was measured every other day. After dissection, blood and tissues were collected from the mice. RESULTS: The administration of EFAY reduced body and organ weights significantly compared to HFD-fed control mice. The EFAY-administered groups also improved the serum lipid profile by decreasing the triglyceride, total cholesterol, and low-density lipoprotein compared to the control group. In addition, EFAY ameliorated the insulin resistance-related metabolic dysfunctions, including the fasting blood glucose and serum insulin level, compared to the HFD-fed control mice. The EFAY inhibited lipid synthesis and insulin resistance by down-regulation of hepatic fatty acid synthase and up-regulation of the AMP-activated protein kinase pathway. EFAY also reduced lipid peroxidation in the liver, indicating that EFAY protected hepatic injury induced by obesity. CONCLUSIONS: These results suggest that EFAY improved obesity-associated insulin resistance by regulating the lipid and glucose metabolism, suggesting that AY could be used as a functional food to prevent obesity and insulin resistance.

참고문헌 (61)

  1. Blüher M, "Adipose tissue dysfunction in obesity", Exp Clin Endocrinol Diabetes, 117, pp.241~250 (2009)
  2. Wang S, "Novel insights of dietary polyphenols and obesity", J Nutr Biochem, 25, pp.1~18 (2014)
  3. Rosen ED, "Adipocytes as regulators of energy balance and glucose homeostasis", Nature, 444, pp.847~853 (2006)
  4. Jung UJ, "Obesity and its metabolic complications : the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease", Int J Mol Sci, 15, pp.6184~6223 (2014)
  5. Klöting N, "Adipocyte dysfunction, inflammation and metabolic syndrome", Rev Endocr Metab Disord, 15, pp.277~287 (2014)
  6. Kopelman PG, "Obesity as a medical problem", Nature, 404, pp.635~643 (2000)
  7. Banack HR, "The obesity paradox : understanding the effect of obesity on mortality among individuals with cardiovascular disease", Prev Med, 62, pp.96~102 (2014)
  8. Blair SN, "Effects of physical inactivity and obesity on morbidity and mortality : current evidence and research issues", Med Sci Sports Exerc, 31(Suppl), pp.S646~S662 (1999)
  9. 김아련, "Phenolic compounds with IL-6 inhibitory activity from Aster yomena", Archives of Pharmacal Research, 37(7), pp.845~851 (2014), 대한약학회[DOI]
  10. 서상완, "쑥부쟁이 에탄올 추출물의 급성췌장염 보호 효과", 동의생리병리학회지, 33(2), pp.109~115 (2019), 한의병리학회[DOI]
  11. 정복미, "쑥부쟁이 분획물의 in vitro 암세포증식 억제 및 QR 유도효과", 한국식품영양과학회지, 34(1), pp.8~12 (2005), 한국식품영양과학회
  12. Han MH, "Ethanol extracts of Aster yomena (Kitam.) Honda inhibit adipogenesis through the activation of the AMPK signaling pathway in 3T3-L1 preadipocytes", Drug Discov Ther, 11, pp.281~287 (2017)
  13. 김민정, "쑥부쟁이 추출물의 라디칼 소거활성 평가", 한국산학기술학회논문지, 19(9), pp.402~407 (2018), 한국산학기술학회[DOI]
  14. Kim MJ, "Aster yomena (Kitam.) Honda inhibits adipocyte differentiation in 3T3-L1 cells", Int J Gerontol, 13, pp.S33~S38 (2019)
  15. Fraulob JC, "A mouse model of metabolic syndrome : Insulin resistance, fatty liver and non-alcoholic fatty pancreas disease(NAFPD)in C57BL", 6 mice fed a high fat diet, 2010, pp.46, 212~223
  16. Yang Q, "Plantago asiatica L. seed extract improves lipid accumulation and hyperglycemia in high-fat diet-induced obese mice", Int J Mol Sci, 18, pp.1393~ (2017)
  17. Choi KM, "Sulforaphane attenuates obesity by inhibiting adipogenesis and activating the AMPK pathway in obese mice", J Nutr Biochem, 25, pp.201~207 (2014)
  18. Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge", Clin Chem, 18, pp.499~502 (1972)
  19. Matthews DR, "Homeostasis model assessment : insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man", Diabetologia, 28, pp.412~419 (1985)
  20. Wallace TM, "Use and abuse of HOMA modeling", Diabetes Care, 27, pp.1487~1495 (2004)
  21. Ohkawa H, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction", Anal Biochem, 95, pp.351~358 (1979)
  22. Hill JO, "Environmental contributions to the obesity epidemic", Science, 280, pp.1371~1374 (1998)
  23. Hirsch J, "Adipose tissue cellularity in human obesity", Clin Endocrinol Metab, 5, pp.299~311 (1976)
  24. Bays HE, "Obesity, adiposity, and dyslipidemia : a consensus statement from the National Lipid Association", J Clin Lipidol, 7, pp.304~383 (2013)
  25. Fantuzzi G, "Adipose tissue, adipokines, and inflammation", J Allergy Clin Immunol, 115, pp.911~919 (2005)
  26. Shah A, "Adipose inflammation, insulin resistance, and cardiovascular disease", JPEN J Parenter Enteral Nutr, 32, pp.638~644 (2008)
  27. Chandalia M, "Metabolic complications of obesity : inflated or inflamed?", J Diabetes Complications, 21, pp.128~136 (2007)
  28. Pickup JC, "Is type II diabetes mellitus a disease of the innate immune system?", Diabetologia, 41, pp.1241~1248 (1998)
  29. Zeyda M, "Obesity, inflammation, and insulin resistance--a mini-review", Gerontology, 55, pp.379~386 (2009)
  30. Kang HJ, "An ethanol extract of Aster yomena (Kitam.) Honda inhibits lipopolysaccharide-induced inflammatory responses in murine RAW 264.7 macrophages", Biosci Trends, 11, pp.85~94 (2017)
  31. 이호재, "고지방 식이로 유도된 비만 생쥐에서 쑥부쟁이 에탄올 추출물의 항비만 효과", 동의생리병리학회지, 31(6), pp.348~355 (2017), 한의병리학회[DOI]
  32. Wieser V, "Inflammation, cytokines and insulin resistance: a clinical perspective", Arch Immunol Ther Exp(Warsz), 61, pp.119~125 (2013)
  33. Arçari DP, "Anti-inflammatory effects of yerba maté extract(Ilex paraguariensis)ameliorate insulin resistance in mice with high fat diet-induced obesity", Mol Cell Endocrinol, 335, pp.110~115 (2011)
  34. Hariri N, "High-fat diet-induced obesity in animal models", Nutr Res Rev, 23, pp.270~299 (2010)
  35. Buettner R, "High-fat diets: modeling the metabolic disorders of human obesity in rodents", Obesity(Silver Spring), 15, pp.798~808 (2007)
  36. Woods SC, "A controlled high-fat diet induces an obese syndrome in rats", J Nutr, 133, pp.1081~1087 (2003)
  37. Lin S, "Development of high fat diet-induced obesity and leptin resistance in C57Bl", 6J mice, 2000, pp.24, 639~646
  38. Gallou-Kabani C, "C57BL", 6J and A, Obesity(Silver Spring), pp.2007, 15[DOI]
  39. Messier C, "The effects of a high-fat, high-fructose, and combination diet on learning, weight, and glucose regulation in C57BL", 6 mice, 2007, pp.178, 139~145
  40. Huang Y, "Maternal high folic acid supplement promotes glucose intolerance and insulin resistance in male mouse offspring fed a high-fat diet", Int J Mol Sci, 15, pp.6298~6313 (2014)
  41. Ikemoto S, "High fat diet-induced hyperglycemia : prevention by low level expression of a glucose transporter(GLUT4)minigene in transgenic mice", Proc Natl Acad Sci U S A, 92, pp.3096~3099 (1995)
  42. Rivellese AA, "Type of dietary fat and insulin resistance", Ann N Y Acad Sci, 967, pp.329~335 (2002)
  43. Muniyappa R, "Current approaches for assessing insulin sensitivity and resistance in vivo : advantages, limitations, and appropriate usage", Am J Physiol Endocrinol Metab, 294, pp.E15~E26 (2008)
  44. Sundaresan A, "Ursolic acid and rosiglitazone combination alleviates metabolic syndrome in high fat diet fed C57BL", 6J mice, 2012, pp.31, 323~333
  45. Lelliott C, "Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation", Int J Obes Relat Metab Disord, 28(Suppl 4), pp.S22~S28 (2004)
  46. Leonhardt M, "Fatty acid oxidation and control of food intake", Physiol Behav, 83, pp.645~651 (2004)
  47. Li JZ, "Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation", Diabetes, 56, pp.2523~2532 (2007)
  48. Hsu WH, "Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL", 6 mice, 2014, pp.64, 94~103
  49. Shaw RJ, "The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin", Science, 310, pp.1642~1646 (2005)
  50. Marín-Aguilar F, "Adenosine monophosphate(AMP)-activated protein kinase : a new target for nutraceutical compounds", Int J Mol Sci, 18, pp.288~ (2017)
  51. Lee HA, "Ganoderma lucidum extract reduces insulin resistance by enhancing AMPK activation in high-fat diet-induced obese mice", Nutrients, 12, pp.3338~ (2020)
  52. Zhao L, "Raspberry alleviates obesity-induced inflammation and insulin resistance in skeletal muscle through activation of AMP-activated protein kinase(AMPK)α1", Nutr Diabetes, 8, pp.39~ (2018)
  53. Das N, "leaf extract prevents early liver injury and restores antioxidant status in mice fed with high-fat diet", Indian J Exp Biol, 50, pp.404~412 (2012)
  54. Ha SK, "Inducible nitric oxide distribution in the fatty liver of a mouse with high fat diet-induced obesity", Exp Anim, 59, pp.595~604 (2010)
  55. Shyamala MP, "Antioxidant potential of the Syzygium aromaticum (Gaertn.) Linn. (cloves) in rats fed with high fat diet", Indian J Pharmacol, 35, pp.99~103 (2003)
  56. Noeman SA, "Biochemical study of oxidative stress markers in the liver, kidney and heart of high fat diet induced obesity in rats", Diabetol Metab Syndr, 3, pp.17~ (2011)
  57. 심지현, "Anti-Asthmatic Activities of an Ethanol Extract of Aster yomena in an Ovalbumin-Induced Murine Asthma Model", Journal of Medicinal Food, 17(5), pp.606~611 (2014), 한국식품영양과학회[DOI]
  58. Amirkhizi F, "Is obesity associated with increased plasma lipid peroxidation and oxidative stress in women", ARYA Atheroscler, 2, pp.189~192 (2007)
  59. Kim Y, "Esculetin, a coumarin derivative, suppresses adipogenesis through modulation of the AMPK pathway in 3T3-L1 adipocytes", J Funct Foods, 12, pp.509~515 (2015)
  60. Liao CC, "Prevention of diet-induced hyperlipidemia and obesity by caffeic acid in C57BL", 6 mice through regulation of hepatic lipogenesis gene expression, 2013, pp.61, 11082~11088
  61. Jung UJ, "Apigenin ameliorates dyslipidemia, hepatic steatosis and insulin resistance by modulating metabolic and transcriptional profiles in the liver of high-fat diet-induced obese mice", Nutrients, 8, pp.305~ (2016)

관련 논문AI추천

이 간행물의 다른 논문 (9건)